The shareholders in CellaVision AB are hereby summoned to the Annual
General Meeting, to be held on Monday April 27 2009 at 16.00 at
CellaVision AB, Scheelevägen 19 A, Delta 5, in Lund, Sweden.
The complete notice is available in Swedish only, please click the
link below.
For more information, please contact:
Yvonne Mårtensson, CEO. Phone: 0708 33 77 82, e-mail:
yvonne.martensson@cellavision.se
Johan Wennerholm, CFO. Phone: 0708 33 81 68, e-mail:
johan.wennerholm@cellavision.se
About CellaVision
CellaVision AB develops, markets, and sells market leading image
analysis based systems for routine analysis of blood and other body
fluids. The company has a core competence in development of software
and hardware for automatic image analysis of cells and cell changes
for applications in health and medical care. The company develops and
markets systems for automatic differentials of white blood cells and
red morphology, and software for education and quality assurance of
differentials. The company's associates have expertise in advanced
imaging analysis, artificial intelligence, and automated microscopy.
The company headquarters are in Lund, Sweden. The company also has
subsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan.
For more information, visit www.cellavision.com.
CellaVision's share is listed on First North Premier at the OMX
Stockholm Stock Exchange. The company's Certified Advisor is Remium
AB.
